Home/Filings/3/0001209191-23-002628
3//SEC Filing

WuXi PharmaTech Healthcare Fund I L.P. 3

Accession 0001209191-23-002628

CIK 0001836056other

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 6:34 PM ET

Size

9.1 KB

Accession

0001209191-23-002628

Insider Transaction Report

Form 3
Period: 2023-01-01
Holdings
  • Ordinary Shares

    (indirect: Held by WuXi PharmaTech Healthcare Fund I, L.P.)
    21,270,767
  • Ordinary Shares

    (indirect: Held by WuXi AppTec (Hong Kong) Holding Limited)
    7,996,920
Holdings
  • Ordinary Shares

    (indirect: Held by WuXi AppTec (Hong Kong) Holding Limited)
    7,996,920
  • Ordinary Shares

    (indirect: Held by WuXi PharmaTech Healthcare Fund I, L.P.)
    21,270,767
Holdings
  • Ordinary Shares

    (indirect: Held by WuXi AppTec (Hong Kong) Holding Limited)
    7,996,920
  • Ordinary Shares

    (indirect: Held by WuXi PharmaTech Healthcare Fund I, L.P.)
    21,270,767
Footnotes (3)
  • [F1]The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents seven Ordinary Shares of the Issuer.
  • [F2]Shares are directly held by WuXi PharmaTech Healthcare Fund I, L.P. ("PharmaTech"). PharmaTech is an indirect, wholly owned subsidiary of WuXi AppTec Co., Ltd. ("AppTec Co"), which is the ultimate beneficial owner of PharmaTech and shares voting and investment authority over these shares.
  • [F3]Shares are directly held by WuXi AppTec (Hong Kong) Holding Limited ("AppTec HK"). AppTec HK is an indirect, wholly owned subsidiary of AppTec Co, which is the ultimate beneficial owner of AppTec HK and shares voting and investment authority over these shares.

Issuer

Ambrx Biopharma Inc.

CIK 0001836056

Entity typeother
IncorporatedChina

Related Parties

1
  • filerCIK 0001678057

Filing Metadata

Form type
3
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 6:34 PM ET
Size
9.1 KB